The mean ± SD absolute change in adiponectin levels was −0.23 ± 4.6 μg/ml in PsA patients treated with combined onercept 50 mg and onercept 100 mg (vs placebo, p=0.60) and 0.28 ± 3.23 μg/ml in RA patients treated with adalimumab (vs baseline, p=0.66). The gene discussed is ADIPOQ; the disease is rheumatoid arthritis.